October 28, 2024
Beyfortus® Immunization to Protect Infants from RSV has Begun
September 12, 2024
DUPIXENT® (Dupilumab Injection) Approved in Canada for the Treatment of Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)
No current content.